The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of dovitinib in patients (Pts) progressing on anti-vascular endothelial growth factor (VEGF) therapy.
 
Thomas John Semrad
Consulting or Advisory Role - Amgen; Celgene; Eisai; Genentech; Genzyme (I); Onyx
Research Funding - Astex Pharmaceuticals (Inst); Eisai (Inst); Genentech (Inst); Millennium (Inst); Morphotek (Inst); Novartis (Inst)
 
Edward Jae-hoon Kim
Honoraria - Guardant Health; Pharmacyclics
Consulting or Advisory Role - Bayer; Guardant Health; Momenta Pharmaceuticals; Pharmacyclics
Speakers' Bureau - Guardant Health
Research Funding - Celgene (Inst); OncoMed (Inst)
 
Michael S. Tanaka
No Relationships to Disclose
 
Jacob Sands
No Relationships to Disclose
 
Chris Roberts
Employment - HTG Molecular Diagnostics
Stock and Other Ownership Interests - HTG Molecular Diagnostics; Illumina; Kite, a Gilead company; Response Genetics
Research Funding - HTG Molecular Diagnostics; Response Genetics
Patents, Royalties, Other Intellectual Property - Multiple patents pending with HTG Molecular Diagnostics
Travel, Accommodations, Expenses - HTG Molecular Diagnostics
 
Stephanie H. Astrow
Employment - Kite, a Gilead company; Response Genetics
Leadership - Response Genetics
 
Craig Stephens
Employment - Response Genetics
 
Miriana Moran
Employment - Response Genetics
Stock and Other Ownership Interests - Asterias Biotherapeutics; BioTime; CytRx Corporation; Galena Biopharma; Geron; Peregrine Pharmaceuticals; Vivus
Patents, Royalties, Other Intellectual Property - Response Genetics
 
Rebekah Burich
No Relationships to Disclose
 
Yu Li
No Relationships to Disclose
 
David R. Gandara
Honoraria - Array BioPharma; AstraZeneca; Celgene; Lilly; Novartis; Synta
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Pfizer; Response Genetics; Sanofi; Synta
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); ImClone Systems (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Biomarin; Boehringer Ingelheim; Dava Oncology; Pfizer
 
Primo Lara
Honoraria - Pfizer
Consulting or Advisory Role - Astex Pharmaceuticals; AstraZeneca; Bayer; Clovis Oncology; Exelixis; Genentech/Roche; Halozyme; Immunogen; Janssen; Lilly; LPath; Medivation; Novartis; PER; Pfizer; Sanofi; Teva; US Diagnostic Services
Research Funding - Aragon Pharmaceuticals (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Janssen Biotech (Inst); Merck (Inst); Millennium (Inst); Oncogenex (Inst); Polaris (Inst); TRACON Pharma (Inst)
 
Philip C. Mack
Honoraria - Guardant Health
Consulting or Advisory Role - Apton Biosystems; AstraZeneca; MolecularMD
Research Funding - Boehringer Ingelheim
Travel, Accommodations, Expenses - Guardant Health